Stay updated with breaking news from Qure stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UniQure (NASDAQ:QURE – Get Free Report) has received a consensus rating of “Moderate Buy” from the nine analysts that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that […] ....
Privium Fund Management B.V. lifted its stake in uniQure (NASDAQ:QURE – Free Report) by 6.5% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 281,606 shares of the biotechnology company’s stock after acquiring an additional 17,268 shares during the quarter. Privium Fund Management B.V. owned […] ....
Royal Bank of Canada reiterated their outperform rating on shares of uniQure (NASDAQ:QURE – Free Report) in a research note published on Tuesday, Benzinga reports. The brokerage currently has a $28.00 price target on the biotechnology company’s stock. A number of other brokerages also recently issued reports on QURE. The Goldman Sachs Group raised their […] ....
UniQure (NASDAQ:QURE – Get Free Report) has received a consensus rating of “Buy” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have updated their coverage on the stock in the last […] ....
Shares of uniQure (NASDAQ:QURE – Get Free Report) have earned an average rating of “Buy” from the nine research firms that are covering the company, MarketBeat reports. Nine research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have issued ratings on the stock in the last […] ....